Vedere Bio ll (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2021
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $77,000,000
Company Info
- Company Description
- Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
- Market
- Ocular gene therapies
- Location
- Cambridge, MA, USA
- Coinvestors
- Atlas Venture, Casdin Capital, Mission BioCapital, Octagon Capital, RD Fund, Samsara BioCapital